Company / Return on Equity (ROE)
HARVARD BIOSCIENCE INC Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-19.6%
FY2025
5-year range
-19.6% / -0.4%
FY2021-FY2025
Trend
-319.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
HARVARD BIOSCIENCE INC reports negative total equity of -19.6% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-19.6% in FY2025 with a 5-year CAGR of -13.9%.
Declined from -13.2% to -19.6% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -19.2pp
- 5-Year Change
- -13.9pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 319.3% year-over-year.
- Peak return on equity (roe) was recorded in FY2016.
- Lowest return on equity (roe) in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -19.6% | -319.3% |
| FY2024 | -4.7% | +64.6% |
| FY2023 | -13.2% | -3665.7% |
| FY2022 | -0.4% | +96.6% |
| FY2021 | -10.2% | -79.7% |
| FY2020 | -5.7% | -60.6% |
| FY2019 | -3.5% | -229.9% |
| FY2018 | -1.1% | +95.9% |
| FY2017 | -26.4% | -1167.6% |
| FY2016 | 2.5% | +227.3% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026